# Megatrends One Year Later – #10: Predictive and Preventative Healthcare – What I Predicted, and What’s Actually Happening
By 

## Article Content
“The medicine of tomorrow isn’t about the miracle cure; it’s about the predictive insight that makes the cure unnecessary.” - Futurist Jim Carroll One year ago, in July 2025, I published Megatrend #10: Predictive and Preventative Healthcare as part of my 30 Megatrends series. When I wrote it, the wing-nut-looney-bins were getting more aggressive in US healthcare, so I wrote this in the intro: Medicine is shifting from reactive treatment to anticipatory care through continuous monitoring, AI diagnostics, and early intervention. We are moving from fixing people after they are sick to knowing what they will become sick with and acting accordingly. This creates fundamentally different business models across the health system and massive new business and societal opportunities. The interesting thing about this trend is that while it involves so much promise, it also requires societies that have a mature relationship with science and the future. Given some of the recent events throughout the US, it is becoming obvious that other parts of the world will see greater advancements with this megatrend, and so you need to consider all this from a global perspective. As I said yesterday, long-game proponents know, though, that megatrends always outlast the bombast, particularly at a global scale. The wing-nut-looney-bins are more aggressive, and so that aspect of it has not changed. Hello measles! Anyways, the real science world continues to try to move on. The FDA had authorized over 1,357 AI-enabled medical devices by February 2026 — more than double the 2022 count. 71% of US hospitals now run predictive AI integrated with their electronic health records. Hospitals using AI diagnostics report up to 40% faster diagnosis and 25% fewer misdiagnoses. Adoption of domain-specific clinical AI tools is up 7x year over year. But AI was only one of the four pillars I named a year ago. Genomics moved just as fast: whole-genome sequencing has fallen below $100 a genome on platforms like Ultima Genomics and Illumina’s NovaSeq X Plus, and the personalized medicine market is tracking toward roughly $419 billion this year — ahead of the pace I projected. Digital therapeutics — the “drug treatment on demand” piece of the health Super-App I described — is now a $9.94 billion global market growing at 22.4% a year, on its way past $61 billion by 2034. And remote patient monitoring, the “proactive patient” piece, keeps posting the same result it did a year ago: fewer ER visits, shorter hospital stays, and patient satisfaction consistently above 90% in well-run programs. Verdict: Nailed it, and not just on the AI pillar. All four legs of the proactive-health stool — AI, genomics, digital therapeutics, and remote monitoring — are moving in step, not just the flashiest one.

---
Source: https://jimcarroll.com/2026/08/megatrends-one-year-later-10-predictive-and-preventative-healthcare/